21 commercial payer policies list J9029. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
21 policies from 18 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9029 |
|---|---|---|
| Adstiladrin (nadofaragene firadenovec-vncg) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Adstiladrin (nadofaragene firadenovec-vncg) | Not recorded | Covered with conditionsInferred from policy title |
| Adstiladrin (nadofaragene firadenovec-vncg) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| ADSTILADRIN (nadofaragene firadenovec-vncg) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J9029 |
|---|---|---|
| Nadofaragene Firadenovec-vncg (Adstiladrin) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Nadofaragene firadenovec-vncg (e.g., Adstiladrin) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Prior Authorization Request Form for Adstiladrin (nadofaragene firadenovec-vncg) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| ADSTILADRIN (NADOFARAGENE FIRADENOVEC-VNCG) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Nadofaragene firadenovec-vncg (Adstiladrin) | May 2, 2023 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Adstiladrin (Nadofaragene firadenovec-vncg) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Nadofaragene Firadenovec-vncg (Adstiladrin); CP.PHAR.461 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Q3 - 2026 Jefferson Health Plans MedOnc Master Drug List | Not recorded | Prior auth required |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Oncology - gene therapy for bladder cancer (Adstiladrin) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Nadofaragene Firadenovec-vncg (Adstiladrin) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| 00860 nadofaragene firadenovec-vncg (Adstiladrin) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Adstiladrin | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9029 |
|---|---|---|
| Adstiladrin (nadofaragene firadenovec-vncg) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |